More Like This

CMA wins drug market sharing appeal

CMA sets out provisional view on Vodafone / Three merger

CMA concludes market investigation with major reforms to veterinary sector

Major reforms would require vet businesses to make fundamental changes to the way they support pet owners

PR Newswire associated0

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

PR Newswire associated0

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

Trainline, Virgin Atlantic and RED Driving School investigated for drip pricing

PR Newswire associated0

CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy